The study aim was to assess the abuse/misuse potential of second‐generation
antipsychotics (SGAPs) using VigiBase data. We extracted individual case safety reports of …

Purpose/Background A recent years' increase in both prescribing and availability of second-
generation antipsychotics (SGAs) has been observed. According to the literature, typically …

Background: Second-generation antipsychotics (SGAs) are assumed to have little abuse
potential. However, reports of quetiapine abuse have emerged as prescribing has increased …

Background: Retrospective analyses of large databases of treated patients can provide
useful links to the presence of drug misuse or rare and infrequent adverse effects, such as …

Aims There are increasing concerns about harms related to suboptimal antipsychotic use.
Here we describe recent population‐based trends in antipsychotic use and harms in …

Background Starting in 2007, regulatory agencies strengthened label warnings for
intravenous haloperidol. Based on adverse drug reaction (ADR) reports of QT prolongation …

VERDOUX & BEGAUD VERDOUX & BE¤ GAUD have a serious impact on the health of the
population if many people are exposed to the drug. Surveillance by centralised pooling of …

Background Deaths from antipsychotic (AP) poisoning have increased in England and
Wales despite restriction of the use of thioridazine in 2000. Methods We analyzed data from …

Background Antipsychotics (APs) have been associated with risk of torsade de Pointes
(TdP). This has important public health implications. Therefore,(a) we exploited the public …

Background Persons with symptoms of psychosis receiving treatment with atypical
antipsychotics (AAPs) can experience serious adverse events (AEs) requiring admission to …